Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Top Cited Papers
Open Access
- 2 October 2006
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 116 (10), 2610-2621
- https://doi.org/10.1172/jci24612
Abstract
Inhibitors of VEGF signaling can block angiogenesis and reduce tumor vascularity, but little is known about the reversibility of these changes after treatment ends. In the present study, regrowth of blood vessels in spontaneous RIP-Tag2 tumors and implanted Lewis lung carcinomas in mice was assessed after inhibition of VEGF receptor signaling by AG-013736 or AG-028262 for 7 days. Both agents caused loss of 50%-60% of tumor vasculature. Empty sleeves of basement membrane were left behind. Pericytes also survived but had less alpha-SMA immunoreactivity. One day after drug withdrawal, endothelial sprouts grew into empty sleeves of basement membrane. Vessel patency and connection to the bloodstream followed close behind. By 7 days, tumors were fully revascularized, and the pericyte phenotype returned to baseline. Importantly, the regrown vasculature regressed as much during a second treatment as it did in the first. Inhibition of MMPs or targeting of type IV collagen cryptic sites by antibody HUIV26 did not eliminate the sleeves or slow revascularization. These results suggest that empty sleeves of basement membrane and accompanying pericytes provide a scaffold for rapid revascularization of tumors after removal of anti-VEGF therapy and highlight their importance as potential targets in cancer therapy.Keywords
This publication has 62 references indexed in Scilit:
- Current status of angiogenesis inhibitors combined with radiation therapyCancer Treatment Reviews, 2006
- Inhibition of Experimental Metastasis by Targeting the HUIV26 Cryptic Epitope in CollagenThe American Journal of Pathology, 2006
- Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast CancerJournal of Clinical Oncology, 2006
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Utilization of Bone Marrow-Derived Endothelial Cell Precursors in Spontaneous Prostate Tumors Varies with Tumor GradeCancer Research, 2004
- The contribution of vascular basement membranes and extracellular matrix to the mechanics of tumor angiogenesisAPMIS, 2004
- VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaThe Journal of cell biology, 2003
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixOnline Journal of Public Health Informatics, 1997
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993